MedPath

Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density

Not Applicable
Completed
Conditions
Traumatic Arthritis
Rheumatoid Arthritis
Avascular Necrosis
Legg-Perthes Disease
Osteoarthritis
Interventions
Device: Taperloc Complete Microplasty
Device: Taperloc Complete Standard
Registration Number
NCT02087436
Lead Sponsor
Zimmer Biomet
Brief Summary

The primary purpose of this study is to measure the postoperative changes in bone mineral density, comparing the Taperloc Complete Reduced Distal Microplasty stem and the standard length Taperloc Complete Reduced Distal stem.

Detailed Description

The Taperloc Microplasty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption. The primary aim of this study is therefore to compare the postoperative changes in bone density with the Taperloc Microplasty stem, using the standard length Taperloc stem as a control.

In addition, the Taperloc stem has historically had a neck angle of 138°. There have been criticisms that this neck angle is too high for the typical Korean population. The newer Taperloc Complete system (both Microplasty and standard length) has a neck angle of 133°. A secondary aim is Occurrence ratio of thigh pain difference between Microplasty and standard stem in Korean Population

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients suitable for primary Total Hip Replacement

Patients with degenerative joint disease (inflammatory or non-inflammatory) or any of the composite diagnoses of:

  1. Osteoarthritis
  2. Avascular necrosis
  3. Legg Perthes
  4. Rheumatoid Arthritis
  5. Diastrophic variant
  6. Fused hip
  7. Sequelae of Slipped capital epiphysis
  8. Traumatic arthritis
  9. Patients aged over 20
  10. Patients must be able to understand instructions and be willing to return for follow-up
Exclusion Criteria
  • Absolute contraindications include: infection, sepsis, and osteomyelitis.

Relative contraindications include:

  1. uncooperative patient or patient with neurologic disorders who are incapable of following directions,
  2. Small Femoral canal
  1. Severe osteoporosis (Patients over 65 years old) 3) metabolic disorders which may impair bone formation, 4) osteomalacia, 5) distant foci of infections which may spread to the implant site, 6) rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, and 7) vascular insufficiency, muscular atrophy, or neuromuscular disease. 8) pregnancy 9) Fracture of the pelvis 10) Subcapital fractures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Taperloc Complete MicroplastyTaperloc Complete MicroplastyGroup one will receive a total hip replacement with Taperloc Complete Microplasty.Taperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption.
Taperloc Complete StandardTaperloc Complete StandardGroup one will receive a total hip replacement with Taperloc Complete Standard. Taperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques.
Primary Outcome Measures
NameTimeMethod
Bone Mineral Density1 year

evaluate bone mineral density around the implant

Secondary Outcome Measures
NameTimeMethod
Radiographic Evaluation,2 years

Radiographic measurements of stability and fixation

Radiographic Evaluation6 Weeks

Radiographic measurements of stability and fixation

VAS Score6 Months

The measurement of pain intensity

Bone Mineral DensityImmediate post-op(2 - 4Weeks)

* Two X-ray beams with different energy levels are aimed at the patient's bones.

* DEXA

* evaluate the bone mineral density around the implant

Modified Harris Hip Score6 Months

* Over all Survivorship

* Harris Hip Score

Trial Locations

Locations (2)

Chung-Ang University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath